STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
30
13F, latest reported quarter
What the filings say about VRA
Insiders, 180 days
+$265.0K net bought
3 buyers
Vera Bradley insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Vera Bradley, Inc. insiders bought a net $265.0K of stock across 15 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Dec 12, 2025.
+47.6% median (+47.6% mean) 90-day return after 2 previous buys.
The trade is 21.3% of the 135,623 shares held after it.
1 other insider bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Bickley Ian bought about $111.8K of VRA on Jun 12, 2026; 1 other insider bought within 30 days and 30 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Dec 15, 2025.
+73.3% median (+58.3% mean) 90-day return after 3 previous buys.
The trade is 3.8% of the 650,000 shares held after it.
1 other insider bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Meslow Andrew bought about $93.0K of VRA on Jun 12, 2026; 1 other insider bought within 30 days and 30 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Dec 12, 2025.
+47.6% median (+47.6% mean) 90-day return after 2 previous buys.
The trade is 8.3% of the 600,000 shares held after it.
1 other insider bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Meslow Andrew bought about $96.5K of VRA on Dec 15, 2025; 1 other insider bought within 30 days and 30 funds added in the latest 13F quarter.
15 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
VRA planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
VRA mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Fund
$687.7K position · as of 2026-06-30
0.7%
Royce Micro-Cap Fund
$1.4M position · as of 2026-06-30
0.3%
Royce Capital Fund - Micro-Cap Portfolio
$453.9K position · as of 2026-06-30
0.3%
Ultra-Small Company Market Fund
$175.4K position · as of 2026-06-30
0.1%
iShares Micro-Cap ETF
$260.3K position · as of 2026-06-30
0.0%
EA Bridgeway Omni Small-Cap Value ETF
$335.5K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $265.0K bought by insiders over 180 days, 30 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$274.5M
four quarters, 2025-08-03 to 2026-08-01
Revenue, TTM VRA
FY Jan 2026
$269.7M
FY Feb 2025
n/a
FY Feb 2024
$470.8M
FY Jan 2023
$500.0M
FY Jan 2022
$540.5M
Aug 2026
$71.6M
May 2026
$55.7M
Jan 2026
$84.9M
Nov 2025
$62.3M
Aug 2025
$70.9M
May 2025
$51.7M
Feb 2025
$86.4M
Nov 2024
$80.6M
At each fiscal year end
Single quarter
Net margin, TTM
-3.7%
net income over revenue, 2025-08-03 to 2026-08-01
Net margin, TTM VRA
FY Jan 2026
-17.7%
FY Feb 2025
n/a
FY Feb 2024
+1.7%
FY Jan 2023
-11.9%
FY Jan 2022
+3.3%
Aug 2026
+6.3%
May 2026
-8.7%
Jan 2026
+3.1%
Nov 2025
-19.9%
Aug 2025
-6.6%
May 2025
-64.8%
Feb 2025
-54.4%
Nov 2024
-15.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$29.3M
operating cash flow minus capex, 2025-08-03 to 2026-08-01
Free cash flow, TTM VRA
FY Jan 2026
-$13.3M
FY Feb 2025
-$24.5M
FY Feb 2024
$44.2M
FY Jan 2023
-$21.7M
FY Jan 2022
$34.4M
Aug 2026
$22.3M
May 2026
-$5.6M
Jan 2026
$17.1M
Nov 2025
-$4.5M
Aug 2025
-$6.1M
May 2025
-$19.8M
Feb 2025
$17.3M
Nov 2024
-$25.0M
At each fiscal year end
Single quarter
Debt to equity
0.08x
long-term debt only, 2025-11-01 (9 months older than the period end); equity 2026-08-01
Debt to equity VRA
FY Jan 2026
0.08x
FY Feb 2025
0.00x
FY Feb 2024
0.12x
FY Jan 2023
0.12x
FY Jan 2022
0.09x
Aug 2026
0.08x
May 2026
0.08x
Jan 2026
0.08x
Nov 2025
0.08x
Aug 2025
0.07x
May 2025
0.00x
Feb 2025
0.00x
Nov 2024
0.13x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
3.10x
TTM operating cash flow over long-term debt only, 2025-11-01 (9 months older than the period end)
Cash flow to debt VRA
FY Jan 2026
-1.00x
FY Feb 2025
n/a
FY Feb 2024
1.60x
FY Jan 2023
-0.45x
FY Jan 2022
1.33x
Aug 2026
3.10x
May 2026
0.27x
Jan 2026
-1.00x
Nov 2025
-0.56x
Aug 2025
-2.42x
May 2025
n/a
Feb 2025
n/a
Nov 2024
-0.29x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-7.4%
TTM net income over average of 2025-08-02 and 2026-08-01
Return on equity VRA
FY Jan 2026
-30.8%
FY Feb 2025
-28.3%
FY Feb 2024
+3.1%
FY Jan 2023
-20.6%
FY Jan 2022
+5.6%
Aug 2026
-7.4%
May 2026
-14.1%
Jan 2026
-30.8%
Nov 2025
-55.2%
Aug 2025
-51.1%
May 2025
-44.7%
Feb 2025
-28.3%
Nov 2024
-7.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-4.0%
TTM net income over average of 2025-08-02 and 2026-08-01
Return on assets VRA
FY Jan 2026
-17.7%
FY Feb 2025
-18.1%
FY Feb 2024
+2.0%
FY Jan 2023
-13.0%
FY Jan 2022
+3.5%
Aug 2026
-4.0%
May 2026
-7.9%
Jan 2026
-17.7%
Nov 2025
-32.3%
Aug 2025
-30.3%
May 2025
-27.5%
Feb 2025
-18.1%
Nov 2024
-4.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital VRA
FY Jan 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
+3.6%
FY Jan 2023
n/a
FY Jan 2022
+7.4%
Aug 2026
n/a
May 2026
n/a
Jan 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-5.0%
operating income (EBIT proxy) over average of 2025-08-02 and 2026-08-01 minus current liabilities
Return on capital employed VRA
FY Jan 2026
-14.8%
FY Feb 2025
-10.1%
FY Feb 2024
+3.5%
FY Jan 2023
-24.4%
FY Jan 2022
+6.1%
Aug 2026
-5.0%
May 2026
-9.8%
Jan 2026
-14.8%
Nov 2025
-19.0%
Aug 2025
-16.9%
May 2025
-14.0%
Feb 2025
-10.1%
Nov 2024
-5.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing VRA
FY Jan 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
31.36x
FY Jan 2023
n/a
FY Jan 2022
15.21x
Aug 2026
n/a
May 2026
n/a
Jan 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$146.4M
market value at close 2026-10-26 on 2026-09-08 shares, plus long-term debt only, 2025-11-01 (9 months older than the period end), minus cash 2026-08-01
Enterprise value VRA
FY Jan 2026
$58.6M
FY Feb 2025
$75.1M
FY Feb 2024
$194.4M
FY Jan 2023
$154.8M
FY Jan 2022
$208.4M
Aug 2026
$72.7M
May 2026
$113.0M
Jan 2026
$58.6M
Nov 2025
$64.9M
Aug 2025
$49.0M
May 2025
$43.6M
Feb 2025
$75.1M
Nov 2024
$158.5M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+17.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield VRA
FY Jan 2026
-19.8%
FY Feb 2025
-23.6%
FY Feb 2024
+18.3%
FY Jan 2023
-12.6%
FY Jan 2022
+12.9%
Aug 2026
+30.2%
May 2026
+0.8%
Jan 2026
-19.8%
Nov 2025
-19.9%
Aug 2025
-62.0%
May 2025
-52.6%
Feb 2025
-23.6%
Nov 2024
-11.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing VRA
FY Jan 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
0.14x
Aug 2026
n/a
May 2026
n/a
Jan 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VRA ranks highest on insider conviction (90th percentile) and financial health (77th), and lowest on growth (11th), among Consumer Goods peers.
Profitability
27
Inputs
Return on equity-7.4% · 27 pct, sector of 105
Return on assets-4.0% · 33 pct, sector of 124
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-5.0% · 21 pct, sector of 108
Financial health
77
Inputs
Debt to equity0.08x · 69 pct, sector of 112
Cash flow to debt3.10x · 85 pct, sector of 96
Growth
11
Inputs
Revenue growth, YoY-15.4% · 11 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
90
Inputs
Net Form 4 buying (codes P and S), 180d$265K · 87 pct, sector of 80
Insider buyers, 180d3 · 92 pct, sector of 80
Institutional and government
28
Inputs
Funds adding, latest quarter30 · 28 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
74
Inputs
Short interest, % of float+3.1% · 54 pct, sector of 157
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 102
New text in Risk Factors, latest 10-K+10.0% · 68 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
VRA filings, in plain words
Are Vera Bradley insiders buying or selling VRA?
In the 180 days to 2026-10-28, Vera Bradley insiders were net buyers, a net $265.0K across purchases and sales reported on Form 4, by 3 buyers.
Read the full summary
In the 180 days to 2026-10-28, Vera Bradley insiders were net buyers of VRA, a net $265.0K across purchases and sales reported on Form 4 by 3 buyers. 3 insiders reported purchases in that window. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.